EDISON, N.J., July 7 /PRNewswire/ -- The Peer Group, a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, and an Informed Medical Communications (IMC) company, today announced the launch of Xpert Xchange(SM). Xpert Xchange is the newest innovation in moderated peer influence events whereby two Key Opinion Leaders (KOLs) discuss case studies while utilizing clinical data, product attributes, and prescribing experience in a debate-style format. The true value of the program, though, is the unique inclusion of a Peer Group moderator with expertise in communications and the specific therapeutic area to engage all healthcare provider attendees in active dialogue related to the KOL exchange. This format is consistent with The Peer Group's focus on continually improving and optimizing physician peer influence for their bio-pharmaceutical clients through moderated peer discussion at dinner meetings and other peer influence events.
"Xpert Xchange provides a novel way to highlight KOLs at peer events, by engaging all physicians in active dialogue between each other and simultaneously with the two KOLs," noted Kathleen Bresette, President of The Peer Group. "Recognizing that compelling peer discussion can significantly improve ROI compared to traditional didactic KOL presentations, this innovation is a breakthrough in leveraging the true value of KOL expertise and peer dialogue among professional equals."
The Peer Group recently entered into a relationship with a top-10 pharmaceutical client to deliver a series of Xpert Xchange programs along with a full suite of peer influence events.
About Informed Medical Communications
Informed Medical Communications (http://www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting general and specialty peer-to-peer medical programs, respectively. Additionally, IMC's major businesses are enhanced by MRxHealth, the market research and consulting infrastructure that supports IMC's ongoing development and effectiveness of non-traditional marketing programs for biopharmaceutical clients, and Leading Through Dialogue, a communications training service for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.
|SOURCE Informed Medical Communications|
Copyright©2008 PR Newswire.
All rights reserved